UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Hemolytic disease of the fetus and newborn due to multiple maternal antibodies

American journal of obstetrics and gynecology, 2015-07, Vol.213 (1), p.68.e1-68.e5

2015

Volltextzugriff (PDF)

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

American journal of perinatology reports, 2016-03, Vol.6 (1), p.e129-e132

2016

Volltextzugriff (PDF)

Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle

The journal of maternal-fetal & neonatal medicine, 2016-06, Vol.29 (11), p.1783-1788

2016

Volltextzugriff (PDF)

Management of Pregnancies Complicated by Anti-E Alloimmunization

Obstetrics and gynecology (New York. 1953), 2005-01, Vol.105 (1), p.24-28

2005

Volltextzugriff (PDF)

Management of pregnancies complicated by anti-Fy(a) alloimmunization

Transfusion (Philadelphia, Pa.), 2007-10, Vol.47 (10), p.1858-1861

2007

Volltextzugriff (PDF)

Anti-D in Rh positive pregnancies

American journal of obstetrics and gynecology, 2006-10, Vol.195 (4), p.1158-1162

2006

Volltextzugriff (PDF)

Management of Pregnancies Complicated by Anti-c Isoimmunization

Obstetrics and gynecology (New York. 1953), 2004-01, Vol.103 (1), p.24-30

2004

Volltextzugriff (PDF)

Severe Hemolytic Disease of the Fetus Due to Anti-Kpa Antibody

International Journal of Blood Transfusion and Immunohematology, 2013-09, Vol.3 (3), p.1-4

2013

Volltextzugriff (PDF)

Amnioreduction versus septostomy in twin-twin transfusion syndrome

American journal of obstetrics and gynecology, 2001-11, Vol.185 (5), p.1044-1047

2001

Volltextzugriff (PDF)

Management of pregnancies complicated by anti-Fya alloimmunization

Transfusion (Philadelphia, Pa.), 2007-10, Vol.47 (10), p.1858-1861

2007

Volltextzugriff (PDF)

Passively acquired treponemal antibody from intravenous immunoglobulin therapy in a pregnant patient

Archives of pathology & laboratory medicine (1976), 2002-10, Vol.126 (10), p.1237-1238

2002

Volltextzugriff (PDF)

Relation between transamination of branched-chain amino acids and urea synthesis: evidence from human pregnancy

American journal of physiology: endocrinology and metabolism, 1998-09, Vol.275 (3), p.E423-E431

1998

Volltextzugriff (PDF)

Passively Acquired Treponemal Antibody From Intravenous Immunoglobulin Therapy in aPregnant Patient

Archives of pathology & laboratory medicine (1976), 2002-10, Vol.126 (10), p.1237-1238

2002

Volltextzugriff (PDF)

Management of pregnancies complicated by anti-Fy super(a) alloimmunization

Transfusion (Philadelphia, Pa.), 2007-10, Vol.47 (10), p.1858-1861

2007

Volltextzugriff (PDF)

Glucose, Insulin, Gastric Inhibitory Polypeptide, and Pancreatic Polypeptide Responses to Polycose During Pregnancy

Obstetrics and gynecology (New York. 1953), 1992-04, Vol.79 (4), p.592-596

1992

Volltextzugriff (PDF)

Relation between transamination of branched-chain amino acids and urea synthesis : evidence from human pregnancy

American journal of physiology: endocrinology and metabolism, 1998-09, Vol.38 (3), p.E423-E431

1998

Volltextzugriff (PDF)

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

AJP reports, 2016, Vol.6 (1), p.e129-e132

2016

Volltextzugriff (PDF)

Relation between transamination of branched-chain amino acids and urea synthesis: evidence from human pregnancy

American journal of physiology: endocrinology and metabolism, 1998-09, Vol.275 (3), p.E423

1998

Volltextzugriff (PDF)

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

Proceedings of the National Academy of Sciences - PNAS, 2021-06, Vol.118 (22), p.1

2021

Volltextzugriff (PDF)

Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1365-1379

2007

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Potent and Selective Amidino Bicyclic Factor Xa Inhibitors

Journal of medicinal chemistry, 2000-11, Vol.43 (23), p.4398-4415

2000

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(21)
Berichte
(1)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Hemolytic disease of the fetus and newborn due to multiple maternal antibodies

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle

Management of Pregnancies Complicated by Anti-E Alloimmunization

Management of pregnancies complicated by anti-Fy(a) alloimmunization

Anti-D in Rh positive pregnancies

Management of Pregnancies Complicated by Anti-c Isoimmunization

Severe Hemolytic Disease of the Fetus Due to Anti-Kpa Antibody

Amnioreduction versus septostomy in twin-twin transfusion syndrome

Management of pregnancies complicated by anti-Fya alloimmunization

Passively acquired treponemal antibody from intravenous immunoglobulin therapy in a pregnant patient

Relation between transamination of branched-chain amino acids and urea synthesis: evidence from human pregnancy

Passively Acquired Treponemal Antibody From Intravenous Immunoglobulin Therapy in aPregnant Patient

Management of pregnancies complicated by anti-Fy super(a) alloimmunization

Glucose, Insulin, Gastric Inhibitory Polypeptide, and Pancreatic Polypeptide Responses to Polycose During Pregnancy

Relation between transamination of branched-chain amino acids and urea synthesis : evidence from human pregnancy

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Relation between transamination of branched-chain amino acids and urea synthesis: evidence from human pregnancy

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-( R)-hydroxy- N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4- c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa

Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor

Design, Synthesis, and Biological Evaluation of Potent and Selective Amidino Bicyclic Factor Xa Inhibitors

Suchergebnisse filtern